Bacterial Pneumonia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Application of the Recommendations of the SPLIF (French Society of Infectious Pathology) in a Geriatric Population on the Duration of Treatment for Bacterial Pneumonia
Conditions: Pneumonia, Bacterial; Pneumopathy Sponsors: Centre Hospitalier de Saint-Denis Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials

PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial
This study was registered on July 19, 2022, on the ClinicalTrials.gov registry using reference number: NCT05463406.Trial statusRecruitment started on December 5, 2022, and will be completed on November 3, 2024. Current protocol version is version 3.0, dated April 3, 2023. (Source: Trials)
Source: Trials - January 25, 2024 Category: Research Source Type: clinical trials

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Conditions: Community-acquired Bacterial Pneumonia Interventions: Drug: Omadacycline; Drug: Moxifloxacin Sponsors: Zai Lab (Hong Kong), Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex
Conditions: Hospital-acquired Bacterial Pneumonia; Ventilator-associated Bacterial Pneumonia Interventions: Drug: OMN6; Drug: Placebo Sponsors: Omnix Medical Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

Acute Phase Reactant in Non-COVID-19 Bacterial Pneumonia
Conditions: Pneumonia; Acute-Phase Reaction Intervention: Diagnostic Test: Blood sampling Sponsor: Cairo University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
Condition: Pneumonia, Bacterial Interventions: Drug: CAL02; Drug: Placebo Sponsor: Eagle Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials